Dr. Morrow is currently working in a full-time family practice at the Rutherford  Medical Clinic in Edmonton, Alberta.  He holds a special interest in cosmetic medicine and offers most cosmetic injectables at his clinic.  Previously, he has worked as a rural emergency physician and hospitalist in Leduc.  He is currently an Assistant Clinical Professor at the University of Alberta in the department of family medicine. Dr Morrow has received awards for his work in research and medical education.

Dr. Morrow has completed advanced training in the use of cosmetic injectables including the use of neuromodulators such as Botox®, Dysport® and hyaluronic acid fillers. He has trained with several physicians at the forefront of cosmetic medicine–both in Canada and the United States.  He is a member of the Canadian Association of Aesthetic Medicine.  Dr. Morrow is an active member of Mensa Canada® and American Mensa®.

jarret-pic-3

A Little Bit About Dr. Morrow…

Dr. Morrow grew up in Canada with a diverse background and interest in sports.  During high school, he competed on his school swim team (Harry Ainlay Composite) as well as on the Alberta Provincial Cycling and Provincial Biathlon (winter) teams.  While competing in bicycle racing, he won numerous events including at the Alberta Provincial Cycling Championships (individual pursuit, road race, and time trial).  He also placed 3rd in the Canadian National Cycling Championships.

dr-morrow-family

More About Dr. Morrow…

Dr. Morrow is a husband to his wife Katherine and father to his son Tyler.

Dr. Morrow received his Doctor of Medicine from  the University of Alberta in June 2001 and prior to that, received his Bachelor of Science with Specialization in Pharmacology with Distinction, also from the University of Alberta, in June 1997.

He went on to complete is residency training in family medicine, also at the University of Alberta, 2013.

MembershipsMensaMemberLogo

  • Canadian Medical Association
  • Alberta Medical Association
  • College of Physicians and Surgeons of Alberta (link)
  • College of Family Physicians of Canada
  • Canadian Association of Aesthetic Medicine
  • Mensa Canada and American Mensa.

Dr. Morrow is the former President and Chief Science Officer of University Health Industries.  In that capacity, Dr. Morrow worked in formulating nutraceutical products which were marketed in National TV advertising campaigns in the United States.

Other Useful Links

  • Canadian Association of Aesthetic Medicine profile (link)
  • You can also reference his Google Scholar Page: here.

Selected Publications:

  1. Donna Manca; Kim Duerksen; Brian Forst; Dave Jackson; Karim Keshavjee; Ken Martin; Jarret Morrow; Rick Birtwhistle.  The Canadian Primary Care Sentinel Surveillance Network: Knowledge Exchange by Bridging the Evidence-Practice Gap.  NAPCRG Meeting.  November 15, 2011
  2. Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus.  Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.  J Psychopharmacol. 2011 Jan;25(1):71-7 [Pubmed]
  3. Psychiatric Clinical Skills, Revised 1ST edition.  Jarret Morrow, Mark Katz, Gary Rodin.  Editor:  David S. Goldbloom.  Publisher:  Center for Addiction and Mental Health, Toronto.  2010.  Chapter 16 “Assessment of Medical/Surgical Patients.” [CAMHX.ca]
  4. Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus.  Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.  Journal of Psychopharmacology;2009: October 13th. [sagepub.com]
  5. Jarret D. Morrow, Mark Katz, Gary Rodin.  Assessment of Medical/Surgical Patients.  Psychiatric Clinical Skills.  Editor:  David S. Goldbloom.  Publisher:  Elsevier.  Toronto, Ontario. 2006. 215-227. [Google Books]
  6. Morrow J, Castillo M, Gill L, Bradley J, Lara N, Chrapko W, Le Melledo J.  Antipanic Effects of Paroxetine on the Panic Response to Pentagastrin in Healthy Controls and Patients with Panic Disorder.  Psychosomatic Medicine 2004; 64 Abstract #1585.
  7. Morrow J, Tait G, McManus K, Bellavance F, Lara N, and Le Mellédo J. Pentagastrin-induced Release of Free Fatty Acids in Healthy Volunteers and Patients with Panic Disorder.  Effect of Pretreatment with Ethinyl Estradiol.  J Psychiatry Neurosci 2003;28(2):127-33. [Pubmed.com]
  8. Morrow J, Tait G, McManus K, Bellavance F, Lara N, and Le Mellédo J. Pentagastrin-induced Hemoconcentration in Healthy Volunteers and Patients with Panic Disorder.  Effect of Pretreatment with Ethinyl Estradiol.  Psychosomatic Medicine 2002;64(1): 117 (Abstract).
  9. Le Melledo J-M, Lara N, Bailey D, Morrow J, Archer S, Juracz P, Radomski M, Chrapko W, Baker G, Bellavance F.  Anxiety Disorders and cerebro-cardiovascular risks.  ADAA Toronto, March 2003.7.
  10. Le Melledo J-M, McManus K, Tait G, Morrow J, Bellavance F. Investigation of the Cardiovascular Risks Associated with Panic Disorder.  Biological Psychiatry meeting, Washington 1999.
  11. Le Melledo J-M, McManus K, Tait G, Morrow J, Bellavance F. Investigation of the Cardiovascular Risks Associated with Panic Disorder.  CCNP meeting, Halifax, June 1999.

Selected Presentations:

  1. Cardiovascular and Lifestyle Risk Factors Associated with Back Pain.  Family Medicine Forum.  Vancouver, November 2013.
  2. Cardiovascular and Lifestyle Risk Factors Associated with Back Pain.  Annual Scientific Assembly, Banff 2013.
  3. Evidence-Based Medicine Approach to Nutraceutical Development.  Natural Product’s Association Conference.  Las Vegas, Nevada.  July 22nd, 2007.
  4. Jarret Morrow.  A Review of the Cerebro/Cardiovascular Risks Associated with Panic Disorder and the Treatment Implications Pertaining to SSRI’s.  CANMAT Mood and Anxiety Disorder Conference.  Calgary, Alberta.  November 2005.
  5. S-Adenosyl Methionine (SAMe) A Review of the Medical Literature Pertaining to its use in the Treatment of Depressive Disorders.  Grand Rounds, University of Alberta Hospital, Edmonton, June 2004.
  6. The Neurobiology of Panic Disorder:  New Evidence for the Interaction of Cholecystokinin and Serotonin Receptors in the Etiology and Treatment of Panic Disorder.  Alberta Psychiatric Association Meeting.  Banff.  March 2004.  (Lundbeck Award for best original research presentation by a resident.)
  7. Jarret Morrow.  The Effect of Pretreatment with Zoloft on Panic-Induced Hemoconcentration in Healthy Volunteers and Patients with Panic Disorder.  American Psychosomatic Society 61st  Annual Scientific Meeting, Orlando, Florida March 2004.
  8. Morrow J, Bedard A, Tannock R, Ickowicz A.  Comparing Behavioral Response to MPH in ADHD Inattentive and Combined Subtypes.  Presented at the Alberta Psychiatric Association Meeting, Banff. March 2003.
  9. Cerebrovascular Risk Associated with Panic Disorder due to Transient Cholesterol Elevations During Panic Attacks.  Presented at the American Psychosomatic Society 60th Annual Scientific Meeting, Barcelona, Spain.  March 2002.
  10. Cerebrovascular Risk Associated with Panic Disorder.  Presented at the Alberta Psychiatric Association Meeting, Banff. March 2002.
  11. Prinzmetal’s Variant Angina, a Case Report.  Presented at Cardiology Grand Rounds, Royal Alexandra Hospital, Edmonton. April 2002.
  12. The Mind/Body Interaction.  Can emotions/mood states have physiological consequences?  Grand Rounds, Grey Nuns Hospital, Edmonton, December 2001.
  13. Cardiovascular Risks Associated with Panic Disorder.  Presented at the 31st  Annual Medical Student’s Research Day.  Edmonton. September 1998.